How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Ashkenazi has been key to managing the windfall in revenue and wave of investor optimism from Eli Lilly's diabetes injection
Read More
Biotech and Pharmaceuticals
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
Nearly 75% of patients who took the cancer vaccine and Keytruda were alive without any signs or symptoms of their
Read More
FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its
Read More
Pfizer’s drug for advanced lung cancer shows promising long-term trial results
The company's medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for
Read More
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
The tracker could be a valuable tool for Americans scrambling to find GLP-1s, such as Novo Nordisk's weight loss injection
Read More
Two CVS retail stores in Rhode Island join new national pharmacy union
The votes at the CVS stores signal growing momentum in a movement to help thousands of U.S. pharmacy workers address
Read More
Here’s how U.S. health officials are responding to bird flu in humans after second case
A strain of bird flu called H5N1 has been confirmed in dairy cows in nine U.S. states, along with two
Read More
This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma. Source link
Read More
A corner of the cancer therapy market is heating up—Here are the names investors need to know
Radiopharmaceuticals seek to destroy cancer cells by binding a radioactive particle to a targeted molecule and then dispatching it directly
Read More